Cargando…
Efficacy of the LNG-IUS for treatment of endometrial hyperplasia and early stage endometrial cancer: Can biomarkers predict response?
Endometrial Cancer (EC) is the most common gynaecologic malignancy in the developed world, and is increasing in premenopausal women. The surgical standard of care for early-stage EC is not possible in women with concurrent comorbidities or women who desire a fertility sparing approach. The Levonorge...
Autores principales: | Dore, Molly, Filoche, Sara, Danielson, Kirsty, Henry, Claire |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933258/ https://www.ncbi.nlm.nih.gov/pubmed/33718563 http://dx.doi.org/10.1016/j.gore.2021.100732 |
Ejemplares similares
-
LNG-IUS treatment of non-atypical endometrial hyperplasia: Can Pipelle endometrial sampling be an accurate method of follow-up evaluation?
por: Kim, Mi Kyoung, et al.
Publicado: (2013) -
LNG-IUS treatment of non-atypical endometrial hyperplasia in perimenopausal women: a randomized controlled trial
por: Abu Hashim, Hatem, et al.
Publicado: (2013) -
The current situation of the levonorgestrel intrauterine system (LNG-IUS) in conservative treatment for patients with early-stage endometrial cancer and atypical hyperplasia
por: Chen, Xiaojun
Publicado: (2019) -
Characterisation of Levonorgestrel-Resistant Endometrial Cancer Cells
por: Dore, Molly, et al.
Publicado: (2021) -
Safety, efficacy and patient acceptability of the contraceptive and non-contraceptive uses of the LNG-IUS
por: Bednarek, Paula H, et al.
Publicado: (2010)